STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

TCON TRACON PHARMACEUTICALS INCORPORATED StockScouter® Report

1

StockScouter® Score

TRACON PHARMACEUTICALS INCORPORATED, a company in the sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative
  • The 50-day moving average for TCON is significantly below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that stocks will be neutral, stocks will be , and stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

D
N/A
N/A
F

Previous Ratings